KalVista Pharmaceuticals (KALV) Short-term Investments (2019 - 2024)
Historic Short-term Investments for KalVista Pharmaceuticals (KALV) over the last 5 years, with Q4 2024 value amounting to $86.0 million.
- KalVista Pharmaceuticals' Short-term Investments changed N/A to $86.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $86.0 million, marking a year-over-year change of. This contributed to the annual value of $178.6 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Short-term Investments is $86.0 million.
- KalVista Pharmaceuticals' Short-term Investments' 5-year high stood at $178.6 million during Q2 2024, with a 5-year trough of $32.6 million in Q1 2021.
- In the last 4 years, KalVista Pharmaceuticals' Short-term Investments had a median value of $57.2 million in 2020 and averaged $75.5 million.
- Per our database at Business Quant, KalVista Pharmaceuticals' Short-term Investments crashed by 4740.7% in 2021 and then surged by 10699.47% in 2024.
- KalVista Pharmaceuticals' Short-term Investments (Quarter) stood at $39.7 million in 2020, then fell by 17.92% to $32.6 million in 2021, then surged by 39.66% to $45.5 million in 2023, then skyrocketed by 89.03% to $86.0 million in 2024.
- Its Short-term Investments stands at $86.0 million for Q4 2024, versus $94.2 million for Q4 2024 and $142.4 million for Q3 2024.